How and under which circumstances does a rapid diagnostic pathway for prostate cancer work to reduce anxiety for patients? A realist evaluation based on patient, caregiver and staff perspectives
Authors:
- Katie JonesKJKatie Jones
- Jaynie RanceJRJaynie Rance
- on behalf of West Wales Prostate Cancer Support GroupOGon behalf of West Wales Prostate Cancer Support Group
Open Access
- 8 September 2025
- journal article
- Published by BMJ in BMJ Connections Oncology
- Vol. 2 (1) , e000031
Abstract
Introduction: Referral to a cancer diagnostic pathway is a stressful life event, yet distress may be exacerbated by long waiting times, miscommunications or other avoidable challenges. A model prostate cancer (PCa) rapid diagnostic pathway (RDP) called Prostad has been developed and trialled to reduce the time between referral or diagnosis. This realist evaluation asks how, for whom and under which circumstances this model RDP may reduce anxiety for patients. Research design and methods: We conducted semi-structured realist interviews with staff, carers/ partners of patients and patients exploring how, for whom and under which circumstances the PCa RDP produced intended and unintended outcomes. We also attended monthly programme development meetings and had access to documentation regarding the pathway and its development, which we used to produce theories regarding the contextual and mechanistic factors influencing patient experience of the RDP. Results: We interviewed staff (n=12), patients (n=15) and partners or carers of patients (n=3) to produce five programme theories regarding how patients interact with Prostad to produce outcomes. These theories are organised under five themes: rapidity; communication and virtual consultations; communication and continuity; disempowerment and distress; agency mitigating anxiety. Conclusions: Earlier diagnosis is viewed positively by participants; however, in a context where patients have low expectations of health services, the speed of RDPs needs to be adequately communicated at the time the pathway is introduced to the patient to avoid unnecessary concern regarding the rapidity. Patients value regular and consistent communication, which may help mitigate illness uncertainty and offer a sense of control.Keywords
Funding Information
- Cancer Research UK (PICATR-2022/100013)
This publication has 21 references indexed in Scilit:
- Rapid diagnostic pathways for prostate cancer: A realist synthesisJournal of Cancer Policy, 2024
- Prostad: The development and evaluation of a prostate cancer rapid diagnostic pathway, a protocolmedRxiv, 2024
- Patient Navigation in Cancer Treatment: A Systematic ReviewCurrent Oncology Reports, 2024
- Coping strategies in active and inactive men with prostate cancer: a qualitative studyJournal of Cancer Survivorship, 2021
- ‘One Stop Prostate Clinic’: prospective analysis of 1000 men attending a public same‐day prostate cancer assessment and/or diagnostic clinicAnz Journal of Surgery, 2020
- The frequency, nature and impact of GP-assessed avoidable delays in a population-based cohort of cancer patientsCancer Epidemiology, 2020
- One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosisWorld Journal of Urology, 2019
- General practitioner referrals to one-stop clinics for symptoms that could be indicative of cancer: a systematic review of use and clinical outcomesFamily Practice, 2018
- Phenomenology of Illness2016
- The illness uncertainty concept: A reviewCurrent Pain and Headache Reports, 2009